Status | Study |
Active, not recruiting |
Study Name: Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia Condition: Acute Biphenotypic Leukemia Acute Myeloid Leukemia Date: 2013-03-01 Interventions: Other: Laboratory Biomarker Analysis |
Terminated |
Study Name: Acute Lymphoblastic Leukemia Registry at Asan Medical Center Condition: Leukemia, Acute Lymphoblastic Precursor B-Cell Lymphoblastic Leukemia Date: 2013-01-03 Interventions: Other: Diagnosed as ALL All patients who will be enrolled in this prospective registry are confined to t |
Recruiting |
Study Name: Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes Condition: Acute Biphenotypic Leukemia Acute Erythroid Leukemia Date: 2012-09-19 Interventions: Drug: Cyclophosphamide Given I |
Recruiting |
Study Name: Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies Condition: Acute Biphenotypic Leukemia Acute Erythroid Leukemia in Remissi Date: 2009-12-08 Interventions: Drug: Cyclophosphamide Given I |
Completed |
Study Name: Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation Condition: Leukemia Lymphoma Allogeneic Haematopoietic Stem Cell Tran Date: 2009-10-02 Interventions: Drug: Busulfan Test Dose 32 mg |
Recruiting |
Study Name: Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant Condition: Acute Biphenotypic Leukemia Adult Acute Lymphoblastic Leukemia Date: 2008-11-21 Interventions: Drug: Cyclosporine Given IV or |
Recruiting |
Study Name: Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease Condition: Acute Biphenotypic Leukemia Acute Myeloid Leukemia Arising From Date: 2008-07-19 Interventions: Drug: Cyclophosphamide Given I |
Completed |
Study Name: Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies Condition: Hodgkin Lymphoma Lymphocytic Leukemia Date: 2001-03-20 Interventions: Procedure: Stem cell transplantation >3 x 106/kg CD34+ stem cells by IV infusion |